|
Market Closed -
NYSE
00:00:02 20/11/2026 +03
|
Pre-market 15:04:17 | |||
| 80.04 USD | -1.61% |
|
80.06 | +0.02% |
| 11-19 | Health Care Down as Insurers Slide -- Health Care Roundup | DJ |
| 11-18 | UnitedHealthcare to expand program paying pharmacists for medical services | RE |
| Market Cap | 102B 93.3B 86.37B 78.13B 147B 9,564B 153B 1,044B 414B 5,168B 384B 376B 16,372B | P/E 2026 * |
11.4x | P/E 2027 * | 10.9x |
|---|---|---|---|---|---|
| Enterprise Value | 156B 142B 131B 119B 223B 14,531B 233B 1,586B 629B 7,852B 584B 571B 24,873B | EV / Sales 2026 * |
0.37x | EV / Sales 2027 * | 0.35x |
| Free-Float |
71.21% | Yield 2026 * |
3.31% | Yield 2027 * | 3.41% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CVS | Delayed | |
| CVS | Real-time | ||
| CVS | Real-time | ||
| 0HRS | Delayed | ||
| CVSUS | End-of-day quote | ||
| CVS * | End-of-day quote | ||
| CVS | End-of-day quote | ||
| CVSCL | End-of-day quote | ||
| CVS | Real-time | ||
| CVS | Delayed | ||
| Real-time | |||
| CVS | Delayed | ||
| CVS | Delayed | ||
| CVS | End-of-day quote | ||
| 1CVS | End-of-day quote | ||
| 0HRS | Real-time | ||
| CVS | Delayed | ||
| CVS | Delayed |
Last Transcript: CVS Health Corporation
| 1 day | -1.61% | ||
| 1 week | -10.86% | ||
| Current month | -11.31% | ||
| 1 month | -13.64% | ||
| 3 months | -14.53% | ||
| 6 months | -15.01% | ||
| Current year | +0.86% |
| 1 week | 78.98 | 90.71 | |
| 1 month | 77.33 | 95.26 | |
| Current year | 69.51 | 110.68 | |
| 1 year | 69.51 | 110.68 | |
| 3 years | 43.56 | 110.68 | |
| 5 years | 43.56 | 111.25 | |
| 10 years | 43.56 | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 17/10/2024 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 01/03/2007 |
Anne Finucane
BRD | Director/Board Member | 73 | 20/01/2011 |
| Director/Board Member | 71 | 05/03/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/6/26 A | Buy | Executive/Senior Manager | 23,855 | 0.0019% | ||
| 5/31/26 A | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 5/31/26 A | Tax | Chief Technology Officer | -7,618 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.61% | -10.86% | +4.56% | +16.32% | 102B | ||
| -3.36% | -8.06% | -4.31% | +86.84% | 96.16B | ||
| +0.15% | -10.22% | +32.78% | +441.70% | 42.04B | ||
| -3.05% | +0.13% | +14.29% | +95.31% | 32.01B | ||
| -0.51% | -0.92% | +41.58% | +74.23% | 29.95B | ||
| -0.23% | -0.22% | +39.33% | +92.08% | 28.5B | ||
| -2.86% | -8.11% | +35.70% | +313.54% | 20.98B | ||
| -0.62% | -2.67% | -16.84% | -20.10% | 19.4B | ||
| 0.00% | -0.38% | -2.83% | +32.77% | 16.97B | ||
| -6.32% | -10.40% | +98.45% | - | 13.34B | ||
| Average | -1.84% | -5.06% | +24.27% | +125.85% | 40B | |
| Weighted average by Cap. | -1.89% | -6.71% | +14.79% | +111.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 422B 385B 356B 322B 604B 39,416B 632B 4,303B 1,707B 21,299B 1,583B 1,550B 67,470B | 431B 393B 364B 329B 617B 40,292B 646B 4,398B 1,745B 21,773B 1,619B 1,585B 68,970B |
| Net income | 9B 8.2B 7.59B 6.86B 12.87B 840B 13.47B 91.7B 36.38B 454B 33.75B 33.04B 1,438B | 9.41B 8.57B 7.94B 7.18B 13.47B 879B 14.1B 95.94B 38.06B 475B 35.31B 34.57B 1,505B |
| Net Debt | 53.18B 48.45B 44.85B 40.57B 76.1B 4,966B 79.65B 542B 215B 2,684B 200B 195B 8,501B | 48.78B 44.44B 41.14B 37.21B 69.81B 4,555B 73.06B 497B 197B 2,462B 183B 179B 7,798B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/11/26 | $80.04 | -1.61% | 15,944,964 |
| 18/11/26 | $81.35 | -5.20% | 17,590,766 |
| 17/11/26 | $85.81 | -3.14% | 13,620,793 |
| 16/11/26 | $88.59 | -0.85% | 11,780,922 |
| 13/11/26 | $89.35 | -0.49% | 8,019,995 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions

















